Cinobufacini-induced HeLa cell apoptosis enhanced by curcumin

Chinese Science Bulletin

Volumn 58, Issue 21, 2013, Pages 2584-2593

  Liu, Li ^a   Jin, Hua ^a   Ou, JinLai ^a   Jiang, JinHuan ^a   Pi, Jiang ^a   Ke, ChangHong ^a   Yang, Fen ^a   Qiao, DongJuan ^a   Cai, HuaiHong ^a   Cai, JiYe ^a  

^a JINAN UNIVERSITY   (China)

Author keywords

AFM; apoptosis; HeLa cells; MMP; ROS; ultrastructure

Indexed keywords

EID: 84880586387     PISSN: 10016538     EISSN: 18619541     Source Type: Journal    
DOI: 10.1007/s11434-013-5739-9     Document Type: Article

References (52)

1. Bonomi P, Blessing J A, Stehman F B, et al. Randomized trial of three cisplatin dose schedules in squamous-cell carcinoma of the cervix: A Gynecologic Oncology Group study. J Clin Oncol, 1985, 3: 1079-1085.
2. Omura G A. Chemotherapy for cervix cancer. Semin Oncol, 1994, 21: 54-62.
3. McGuire W P, Blessing J A, Moore D, et al. Paclitaxel has moderate activity in squamous cervix cancer. A Gynecologic Oncology Group study. J Clin Oncol, 1996, 14: 792-795.
4. Sutton G P, Blessing J A, McGuire W P, et al. Phase II trial of ifosfamide and mesna in patients with advanced or recurrent squamous carcinoma of the cervix who had never received chemotherapy: A Gynecologic Oncology Group study. Am J Obstet Gynecol, 1993, 168: 805-807.
5. Muderspach L I, Blessing J A, Levenback C, et al. A phase II study of topotecan in patients with squamous cell carcinoma of the cervix: A Gynecologic Oncology Group study. Gynecol Oncol, 2001, 81: 213-215.
6. Long III H J, Bundy B N, Grendys E C, et al. Randomized phase III trial of cisplatin with orwithout topotecan in carcinoma of the uterine cervix: A Gynecologic Oncology Group study. J Clin Oncol, 2005, 23: 4626-4633.
7. Luk J M, Wang X, Liu P, et al. Traditional Chinese herbal medicines for treatment of liver fibrosis and cancer: From laboratory discovery to clinical evaluation. Liver Int, 2007, 27: 879-890.
8. Zuo X D, Cui Y A, Qin S K, et al. Clinical research progress on the antitumor effects of cinobufacini (in Chinese). Chin Clin Oncol, 2003, 8: 232-235.
9. Zuo X D, Cui Y A, Qin S K, et al. Effect of cinobufacini on tumor cell cycle and expression of Bcl-2 protein (in Chinese). Mod J Integr Chin Tradit West Med, 2003, 12: 567-568.
10. Deshpande S S, Maru G B. Effects of curcumin on the formation of benzo [a] pyrene derived DNA adducts in vitro. Cancer Lett, 1995, 96: 71-80.
11. Sharma R A, Gescher A J, Steward W P. Curcumin: The story so far. Eur J Cancer, 2005, 41: 1955-1968.
12. Maheshwari R K, Singh A K, Gaddipati J, et al. Multiple biological activities of curcumin: A short review. Life Sci, 2006, 78: 2081-2087.
13. Ono K, Hasegawa K, Naike H, et al. Curcumin has potent anti-amyloidogenic effects for Alzheimer's beta-amyloidfibrils in vitro. Neurosci Res, 2004, 75: 742-750.
14. Aggarwal B B, Kumar A, Bharti A C. Anticancer potential of curcu min: Preclinical and clinical studies. Anticancer Res, 2003, 23: 363-398.
15. Syng-ai C, Kumari A L, Khar A. Effect of curcumin on normal and tumor cells: Role of glutathione and Bcl-2. Mol Cancer Ther, 2004, 3: 1101-1108.
16. Kunwar A, Barik A, Mishra B, et al. Quantitative cellular uptake, localization and cytotoxicitof curcumin in normal and tumor cells. Biochim Biophys Acta-Gen Subj, 2008, 1780: 673-679.
17. Scarlett J L, Sheard P W, Hughes G, et al. Changes in mitochondrial membrane potential during staurosporine-induced apoptosis in Jurkat cells. FEBS Lett, 2000, 475: 267-272.
18. Puech P H, Poole K, Knebel D, et al. A new technical approach to quantify cell-cell adhesion forces by AFM. Ultramicroscopy, 2006, 106: 637-644.
19. Alarmo E, Pärssinen J, Ketolainen J M, et al. BMP7 influences proliferation, migration, and invasion of breast cancer cells. Cancer Lett, 2009, 275: 35-43.
20. Heidemann S R, Wirtz D. Towards a regional approach to cellmechanics. Trends Cell Biol, 2004, 14: 160-166.
21. Suresh S. Biomechanics and biophysics of cancer cells. Acta Mater, 2007, 55: 3989-4014.
22. Shimizu S, Eguchi Y, Kamiike W. Induction of apoptosis as well as necrosis by hypoxia and predominant prevention of apoptosis by Bcl-2 and Bcl-XL. Cancer Res, 1996, 56: 2161-2166.
23. Grzanka A, Grzanka D, Orlikowska M. Cytoskeletal reorganization during process of apoptosis induced by cytostatic drugs in K-562 and HL-60 leukemia cell lines. Biochem Pharmacol, 2003, 66: 1611-1617.
24. Melanie H, Amanda M G V, Pieter S, et al. Rho-kinase-dependent F-actin rearrangement in involved in the inhibition of PI3-kinase/Akt during ischemia-reperfusion-induced endothelial cell apoptosis. Apoptosis, 2008, 13: 404-412.
25. Olivia N T, Jocelyne H, Jacqueline B. Cytoskeleton and apoptosis. Biochem Pharmacol, 2008, 76: 11-18.
26. Escobar M L, Echeverría R O, Vázquez-Nin G H. Combined apoptosis and autophagy, the process that eliminates the oocytes of atretic follicles in immature rats. Apoptosis, 2008, 13: 1253-1266.
27. Lekka M, Laidler P. Applicability of AFM in cancer detection. Nat Nanotechnol, 2009, 4: 72-73.
28. Jin H, Huang X, Chen Y, et al. Photoinactivation effects of hematoporphyrin monomethyl ether on Gram-positive and -negative bacteria detected by atomic force microscopy. Appl Microbiol Biotechnol, 2010, 88: 761-770.
29. Christian L G, Lesniewska E, Giocondi M, et al. Imaging of the surface of living cells by low-force contact-mode atomic force microscopy. Biophys J, 1998, 75: 695-703.
30. Wang M, Ruan Y X, Chen Q, et al. Curcumin induced HepG2 cell apoptosis-associated mitochondrial membrane potential and intracellular free Ca2+ concentration. Eur J Pharmacol, 2011, 650: 41-47.
31. Denning T L, Takaishi H, Crowe S E, et al. Oxidative stress induces the expression of Fas and Fas ligand and apoptosis in murine intestinal epithelial cell. Free Radic Biol Med, 2002, 33: 1641-1650.
32. Lin Y, Choksi S, Shen H M, et al. Tumor necrosis factor-induced nonapoptotic cell death requires receptor-interacting protein-mediated cellular reactive oxygen species accumulation. J Biol Chem, 2004, 279: 10822-10828.
33. Ortiz-Sánchez E, Daniels T R, Helguera G, et al. Enhanced cytotoxicity of an anti-transferrin receptor IgG3-avidin fusion protein in combination with gambogic acid against human malignant hematopoietic cells: Functional relevance of iron, the receptor, and reactive oxygen species. Leukemia, 2009, 23: 59-70.
34. Trachootham D, Zhou Y, Zhang H, et al. Selective killing of oncogenically transformed cells through a ROS-mediated mechanism by β-phenylethyl isothiocyanate. Cancer Cell, 2006, 10: 241-252.
35. Lu M, Bi C S, Gong X G, et al. Anti-proliferative effects of recombinant iron superoxide dismutase on HepG2 cells via a redox-dependent PI3k/Akt pathway. Appl Microbiol Biotechnol, 2007, 76: 193-201.
36. Raj L, Ide T, Gurkar A U, et al. Selective killing of cancer cells by a small molecule targeting the stress response to ROS. Nature, 2011, 475: 231-234.
37. Orrenius S, Zhivotovsky B, Nicotera P. Regulation of cell death: The calcium-apoptosis link. Nat Rev Mol Cell Biol, 2003, 4: 552-565.
38. Jared L S, Philip W S, Gillian H, et al. Changes in mitochondrial membrane potential during staurosporine-induced apoptosis in Jurkat cells. FEBS Lett, 2000, 475: 267-272.
39. Douglas R G, Guido K. The pathophysiology of mitochondrial cell death. Science, 2004, 305: 626-629.
40. Waterhouse N J, Goldstein J C, Ahsen O V, et al. Cytochrome c maintains mitochondrial transmem-brane potential and ATP generation after outer mitochondrial membrane perme-abilization during the apoptotic process. J Cell Biol, 2001, 153: 319-328.
41. Hu W, Kavanagh J J. Anticancer therapy targeting the apoptotic pathway. Lancet Oncol, 2003, 4: 721-729.
42. Li Y H, Li X L, Wong Y S, et al. The reversal of cisplatin-induced nephrotoxicity by selenium nanoparticles functionalized with 11-mercapto-1-undecanol by inhibition of ROS-mediated apoptosis. Biomaterials, 2011, 32: 9068-9076.
43. Huang C H, Jin H, Song B, et al. The cytotoxicity and anticancer mechanisms of alterporriol L, a marine bianthraquinone, against MCF-7 human breast cancer cells. Appl Microbiol Biotechnol, 2012, 93: 777-785.
44. Wang X. The expanding role of mitochondria in apoptosis. Genes Dev, 2001, 15: 2922-2933.
45. Salganik R I. The benefits and hazards of antioxidants: Controlling apoptosis and other protective mechanisms in cancer patients and the human population. J Am Coll Nutr, 2001, 20: 464S-472S.
46. Shackelford R E, Kaufmann W K, Paules R S. Oxidative stress and cell cycle checkpoint function. Free Radic Biol Med, 2000, 28: 1387-1404.
47. Ma L N, Song B, Jin H, et al. Cinobufacini induced MDA-MB-231 cell apoptosis-associated cell cycle arrest and cytoskeleton function. Bioorg Med Chem Lett, 2012, 22: 1459-1463.
48. Paul S B, Yisang Y, James L R, et al. Calcium, ATP, and ROS: A mitochondrial love-hate triangle. Am J Physiol Cell Physiol, 2004, 287: 817-833.
49. Shih C M, Ko W C, Wu J S, et al. Mediating of caspase-independent apoptosis by cadmium through the mitochondria-ROS pathway in MRC-5 fibroblasts. J Cell Biochem, 2004, 91: 384-397.
50. Nicotera P, Bellomo G, Orrenius S. Calcium-mediated mechanisms in chemically induced cell death. Annu Rev Phar-Macol Toxicol, 1992, 32: 449-470.
51. Melanie H, Amanda M G V, Pieter S, et al. Rho-kinase-dependent F-actin rearrangement in involved in the inhibition of PI3-kinase/Akt during ischemia-reperfusion-induced endothelial cell apoptosis. Apoptosis, 2008, 13: 404-412.
52. Olivia N T, Jocelyne H, Jacqueline B. Cytoskeleton and apoptosis. Biochem Pharmacol, 2008, 76: 11-18.